Mercury Biopharmaceutical Corporation (TPEX: 6932)
Taiwan
· Delayed Price · Currency is TWD
13.25
+0.10 (0.76%)
Nov 20, 2024, 9:16 AM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 5.51 billion as of November 22, 2024. Its market cap has decreased by -34.09% in one year.
Market Cap
5.51B
Enterprise Value
5.29B
Revenue
5.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.25
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 5.51B, an increase of 7.96%. That is a compound annual growth rate of 4.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 21, 2024 | 5.43B | -30.23% |
Dec 29, 2023 | 7.78B | 94.15% |
Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition